China Universal Asset Management »

Tscan Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $17k 9.2k 1.82
2025-06-30 $15k 11k 1.45
2025-03-31 $14k 9.8k 1.38
2024-12-31 $32k 10k 3.04

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
BVF
Baker Bros. Advisors
BlackRock
Vanguard Group
Propel Bio Management
Standard Life Aberdeen
Deer Management
Alphabet
Simplify Asset Management
Morgan Stanley
Renaissance Technologies
DC Funds
Tang Capital Management
Geode Capital Management

View all funds holding Tscan Therapeutics